Structure-activity relationship studies of sulfonylpiperazine analogues as novel negative allosteric modulators of human neuronal nicotinic receptors.
Structure-activity relationship studies of sulfonylpiperazine analogues as novel negative allosteric modulators of human neuronal nicotinic receptors.
复制标题
DOI:
10.1021/jm201294r
复制
发表时间:
2011-12-22
影响因子:
7.3
通讯作者:
McKay, Dennis B.
中科院分区:
文献类型:
--
作者:
Henderson, Brandon J.;Carper, Daniel J.;Gonzalez-Cestari, Tatiana F.;Yi, Bitna;Mahasenan, Kiran;Pavlovicz, Ryan E.;Dalefield, Martin L.;Coleman, Robert S.;Li, Chenglong;McKay, Dennis B.
Neuronal nicotinic receptors have been implicated in several diseases and disorders such as: autism, Alzheimer’s disease, Parkinson’s disease, epilepsy, and various forms of addiction. To understand the role of nicotinic receptors in these conditions, it would be beneficial to have selective molecules that target specific nicotinic receptors in vitro and in vivo. Our laboratory has previously identified novel negative allosteric modulators of human α4β2 (Hα4β2) and human α3β4 (Hα3β4) nicotinic receptors. In the following studies, the effects of novel sulfonylpiperazine analogs that act as negative allosteric modulators on both Hα4β2 nAChRs and Hα3β4 nAChRs were investigated. This work, through structure-activity relationship (SAR) studies, describes the chemical features of these molecules that are important for both potency and selectivity on Hα4β2 nAChRs.
登录
查看更多内容
影响因子:
3.6
作者:
McKay, Dennis B.;Chang, Cheng;Bergmeier, Stephen C.
通讯作者:
Bergmeier, Stephen C.
影响因子:
2.1
作者:
Carpino, LA;El-Faham, A
通讯作者:
El-Faham, A
影响因子:
56.9
作者:
Tapper, AR;McKinney, SL;Lester, HA
通讯作者:
Lester, HA
影响因子:
33.6
作者:
Albuquerque EX;Pereira EF;Alkondon M;Rogers SW
通讯作者:
Rogers SW
影响因子:
4.7
作者:
Grady, Sharon R.;Drenan, Ryan M.;Marks, Michael J.
通讯作者:
Marks, Michael J.